1. Moncada S, Palmer RM, Higgs EA . Nitric oxide: physiology pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109–142.
2. Conti M . Phosphodiesterases and cyclic nucleotide signalling in endocrine cells. Mol Endocrinol 2000; 14: 1317–1327.
3. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S et al. Guanylyl cyclases an signaling by cGMP. Pharmacol Rev 2000; 52: 375–414.
4. Corbin JD, Francis SH, Webb DJ . Phosphodiesterase-type 5 as target in treatment of erectile dysfunction. Urology 2002; 60: 4–11.
5. Salem EA, Kendirici M, Hellstrom WJ . Udenafil, a long-acting PDE5 ihhibitor for erectile dysfunction. Curr Opin Investig Drugs 2006; 7: 661–669.